Drug design and development can be facilitated to target a specific cancer cell. This type of technology can be used when a cancer expresses a specific marker, gene, or characteristic that differentiates it from other, non-cancer cells, in the same body. Direct targeting of a cancer cell can lead to therapies that elicit fewer side effects and better anti-tumor efficacy.